Focus on the production of pharmaceuticals And the intermediate field
Learn more +
ABOUT US
Guangchen Pharmaceutical
Hubei Guangchen Pharmaceutical Co., Ltd., established in 2014 with a registered capital of 40 million yuan, is a pharmaceutical manufacturing enterprise integrating the research, development, production, and sales of raw materials, pharmaceutical intermediates, preparations, and food additives. Adhering to the core corporate philosophy of "using proprietary technology to carefully develop drugs with special indications," the company has established a business model of "raw materials + pharmaceutical intermediates + preparations." It has successively built three raw material production lines and two preparation production lines, with an annual production capacity of 800-1000 tons of raw materials, 50 million tablets, and 200 million capsules. A GMP-compliant pharmaceutical quality management system has been established. The company has successively won numerous honors, including "National High-tech Enterprise," "Hubei Province Specialized, Refined, and New Small Giant Enterprise," and "Hubei Province Science and Technology Innovation Gazelle Enterprise."
Learn more +Company founding date
Testing equipment
Existing employees
PRODUCT
Pharmaceutical raw materials
Pharmaceutical raw materials are the chemical compounds, substances, or ingredients used in the production of drugs or pharmaceutical products.
PRODUCT
Pharmaceutical intermediates
Pharmaceutical intermediates refer to the chemical compounds that are used as building blocks in the synthesis of active pharmaceutical ingredients (APIs).
PRODUCT
Food additives
Chemical or natural substances that are added to food to improve its quality, color, flavor, and aroma, as well as to meet the needs of preservation and processing technology.
PRODUCT
Pharmaceutical excipients
Pharmaceutical excipients are auxiliary materials used in the preparation of drugs that have important functions such as enhancing solubility, aiding dissolution, and controlling release rate.
Pharmaceutical raw materials
Pharmaceutical intermediates
Food additives
Pharmaceutical excipients
ADVANTAGE
Crafted with ingenuity, caring for the health of the people
Through technological accumulation, scientific breakthroughs, quality assurance, and a professional attitude of reverence for life The ultimate social value of achieving the ultimate pursuit of "good medicine benefiting the people" and universal health coverage
Factory equipment +
Complete quality management system
Strong production capacity
Professional research and development system
Well-equipped facilities and equipment
OUR MISSION
Social responsibility
We are committed to participating in charity work, making efforts to give back to society, continuously deepening our presence in rural areas, responding to the national call, and fighting on the front lines of poverty alleviation.
Technological innovation
The company adheres to the corporate tenet of "making good medicine, for health, for life", and contributes to the cause of human health.
Green development
The company has invested heavily in a new sewage treatment system, resolutely implementing the concept that "green mountains and clear water are as valuable as mountains of gold and silver".
NEWS CENTER
Linagliptin/metformin extended-release tablets (I), marketed under the brand name LedaTang®, is a combination antidiabetic formulation manufactured by Hubei Guangchen Pharmaceutical Co., Ltd. and held as the marketing authorization holder; it is also the first extended-release formulation of its kind approved for marketing in China.
2026
10-19
LE DA TANG is a pharmaceutical brand dedicated to the treatment of diabetes, with its flagship product being “LE DA TANG® Linagliptin–Metformin Extended-Release Tablets (I).” This combination antidiabetic formulation contains the DPP‑4 inhibitor linagliptin and the biguanide metformin hydrochloride. Manufactured by Hubei Guangchen Pharmaceutical Co., Ltd., it is the first domestically approved extended-release formulation of its kind, indicated for glycemic control in adult patients with type 2 diabetes who are suitable for treatment with both linagliptin and metformin.
2026
10-19
Ledar Tang® Linagliptin-Metformin Extended-Release Tablets (I) are the first domestically approved extended-release formulation, manufactured by Hubei Guangchen Pharmaceutical Co., Ltd. This product combines the DPP‑4 inhibitor linagliptin with metformin hydrochloride; it is taken once daily, one tablet per dose, with meals, and is indicated, in conjunction with dietary management and exercise, for glycemic control in adult patients with type 2 diabetes who are suitable candidates for treatment with both linagliptin and metformin.
2026
10-19
Carefully develop drugs with special indications using proprietary technology
Customer Service Hotline
Official website: www.hbgcyy.cn
Address: No. 19, Biopark 2nd Road, Biopark Industrial Park, High-tech Zone, Yichang City.
This website supports both IPV4 and IPV6 access.
Copyright © 2023 Guangchen Pharmaceutical ALL RIGHTS RESERVED.